NVSNovartis AG
$143.73+20% 1Y
$143.73
$118.2052 weeks$163.64
NVS as reported
- Operating margin
- 35%
Operating margin · trailing twelve months to Q2 2025
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Gross margin | 80% | n/a | Q2 2025 |
| Operating margin | 35% | n/a | Q2 2025 |
| Net margin | 28% | n/a | Q2 2025 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Novartis AG (NVS) · Revenue and profitRevenue and profitNovartis AG (NVS)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Drug Manufacturers, General
Ranks #2 of 7 by RyuScore